SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001561743-21-000042
Filing Date
2021-06-16
Accepted
2021-06-16 06:44:53
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A a8-kxjune162021.htm DEFA14A 51657
2 EX-2.1 exhibit21mergeragreement-2.htm EX-2.1 689356
3 EX-99.1 exhibit991formofsupportagr.htm EX-99.1 134102
4 EX-99.2 exhibit992pressrelease-212.htm EX-99.2 26989
5 image.jpg GRAPHIC 26243
6 image1.jpg GRAPHIC 30157
  Complete submission text file 0001561743-21-000042.txt   980988
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36225 | Film No.: 211020461
SIC: 2834 Pharmaceutical Preparations